期刊文献+

血栓素A2受体rs768963基因多态性与血小板聚集功能的关系 被引量:5

Relationship Between rs768963 Gene Polymorphism of Thromboxane A2 Receptor and Platelet Aggregation
在线阅读 下载PDF
导出
摘要 目的探讨上海地区汉族人群血栓素A2受体rs768963基因多态性与血小板聚集功能的关系。方法采用聚合酶链反应-限制片长多态性检测59例脑梗死患者和40名对照者的血栓素A2受体rs768963基因多态性基因型,并且测定血小板聚集率。结果脑梗死组甘油三酯浓度和血压水平明显高于对照组,高密度脂蛋白胆固醇浓度明显低于对照组(P<0.05)。对照组rs768963基因突变型(CT型+CC型)与野生型(TT型)比较,血小板1’聚集率明显升高;脑梗死组rs768963基因突变型与野生型比较,血小板1’聚集率和最大聚集率均明显升高。并且全部研究对象的突变型与野生型比较,血小板1’聚集率和最大聚集率也明显升高(P<0.05)。结论血栓素A2受体rs768963基因突变型的血小板聚集率比野生型明显升高,容易引起血栓形成相关疾病。 Aim To investigate the relationship between the thromboxane A2 receptor(TXA2R) gene polymorphism(rs768963) and platelet aggregation in Han people in Shanghai. Methods TXA2R gene types,tested by polymerase chain reaction-restriction fragment length polymorphism(PCR-RFLP),as well as platelet aggregation of 59 cerebral infarction patients and 40 health controls were detected. Results Triglyceride(TG) and blood pressure of cerebral infraction group were significantly higher when high density lipoprotein cholesterol(HDLC) was lower than that of health control(P0.05).Mutant of TXA2R(CT and CC) improves the platelet aggregation(1') in health control group and platelet aggregation(1' and max) in cerebral infarction group,compared with wild type(TT).Studied as a whole group,mutant of TXA2R also had more significant impact on the platelet aggregation(1' and max) than wild type. Conclusion Compared with wild type,mutant of TXA2R(rs768963) improves the platelet aggregation,which may increase the incidence of thrombosis.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2011年第6期525-528,共4页 Chinese Journal of Arteriosclerosis
关键词 血栓素A2受体 基因多态性 血小板聚集功能 Thromboxane A2 Receptor Gene Polymorphism Platelet Aggregation
  • 相关文献

参考文献14

  • 1诸葛欣,张蕴,曹肇慧.血栓素受体在动脉粥样硬化中的作用[J].国外医学(老年医学分册),2008,29(1):9-12. 被引量:2
  • 2Unoki M, Furuta S, Onouchi Y, et al. Association studies of 33 single nucleotide polymorphisms (SNPs) in 29 candidate genes for bronchial asthma: positive association a T924C polymorphism in the thromboxane A2 receptor gene[J]. Hum Genet, 2000, 106 (4) : 440-446.
  • 3Palikhe NS, Kim SH, Lee HY, et al. Association of thromboxane A2 receptor (TBXA2R) gene polymorphism in patients with aspirin- intolerant acute urticaria [ J ]. Clin Exp Allergy, 2011, 41 ( 2 ) : 179-185.
  • 4Kaneko Y, Nakayama T, Saito K, et al. Relationship between the thromboxane A2 receptor gene and susceptibility to cerebral infarc- tion[J]. Hypertens Res, 2006, 29 (9): 665-671.
  • 5赵静,郑岚,傅毅,倪培华,翁迎风,李焕银,邵京山.血栓素A2受体基因多态性与脑梗死的相关性研究[J].中华神经医学杂志,2010,9(12):1228-1230. 被引量:7
  • 6何继强,秦彦文.血小板与动脉粥样血栓[J].中国动脉硬化杂志,2004,12(3):286-286. 被引量:9
  • 7各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33091
  • 8Dogne JM, de Leval X, Hanson J, et al. New developments on thromboxane and prostacyclin modulators part I: thromboxane modulators[J]. Curr Med Chem, 2004, 11 (10) : 1 223-241.
  • 9Offermanns S. Activation of platelet function through G protein-coupled receptors[J]. Circ Res, 2006, 99 (12) : 1 293-304.
  • 10Nusing RM, Hirata M, Kakizuka A, et al. Characterization and chromosomal mapping of the human thromboxane A2 receptor gene [J]. J Biol Chem, 1993, 268 (33) : 25 253-259.

二级参考文献28

  • 1Dognc JM. New developments on thromboxane and prostacyclin modulators part Ⅰ: thromboxane modulators. Curr Med Chem, 2004; 1 1 : 1223 - 1241.
  • 2Pratico D. Acceleration of atherogenesis by COX - 1 dependent prostanold formation in low density lipoprotein receptor knockout mice. Proc Natl Acad Sci USA, 2001 ; 98 : 3358 - 3363.
  • 3Bclton OA. Cyclooxygenasc isoforms and platelet vessel wall interactions in the apolopoprotein E knockout mouse model of atherosclerosis. Circulation, 2003 ; 108 : 3017 - 3023.
  • 4Cyrus T. Effect of low - dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low density lipoprotein receptor - deficient mice. Circulation, 2002 ; 106 : 1282 - 1287.
  • 5Antithrombotic Triallsts Collaboration. Collaborative meta - analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, 2002: 324:71-86.
  • 6The Medical Research Council'S General Practice Research Framework. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with waffarinand lowdose aspirin in the primary prevention of ischaemic heart disease in men at increased risk.Lancet, 1998; 351 : 233 - 241.
  • 7Hiram M, Hayashi Y, Ushikubi F et al. Cloning and expression of cDNA for a human thromboxane A2 receptor. Nature, 1991; 349:617-620.
  • 8Namba T, Sugimoto Y, Hirata M et al. Mouse ihromboxane A2 receptor: cDNA cloning, expression and northern blot analysis. Biochem Biophys Res Commun, 1992; 184: 1197 - 1203.
  • 9Katugampola SD, Davenport AP. Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT ( 1 ) receptor antagonist losartan. Br J Pharmacol, 2001 ; 134:1385 - 1392.
  • 10Cayatte A J, Du Y, Oliver - Krasinski Jet al. The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E - deficient mice: evidence that eicosanoids other than thromboxane contribute to atherosclerosis. Arterioscler Thromb Vasc Biol, 2000; 20: 1724- 1728.

共引文献33109

同被引文献45

  • 1李孟汉,郭义.穴位注射研究进展与展望[J].针灸临床杂志,2010,26(10):69-72. 被引量:61
  • 2Yong Yong SHI,Lin HE.SHEsis,a powerful software platform for analyses of linkage disequilibrium,haplotype construction,and genetic association at polymorphism loci[J].Cell Research,2005,15(2):97-98. 被引量:390
  • 3高维滨,刘勇,倪金霞,朱文增,李晓宁.项针治疗假性延髓麻痹的临床疗效再评价[J].针灸临床杂志,2006,22(9):8-10. 被引量:30
  • 4陈清棠.脑卒中病人临床神经功能缺损程度评分标准(1995).中华神经科杂志,2006,.
  • 5大西幸子,孙启良.摄食吞咽障碍康复实用技术[M].北京:中国医药科技出版杜,2000:63—63.
  • 6S. G.CHU,R. C.BECKER,P. B.BERGER,D. L.BHATT,J. W.EIKELBOOM,B.KONKLE,E. R.MOHLER,M. P.REILLY,J. S.BERGER.Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐analysis[J]. Journal of Thrombosis and Haemostasis . 2009 (1)
  • 7Lippi, Giuseppe,Filippozzi, Luca,Salvagno, Gian Luca,Montagnana, Martina,Franchini, Massimo,Guidi, Gian Cesare,Targher, Giovanni.Increased Mean Platelet Volume in Patients With Acute Coronary Syndromes[J]. Archives of Pathology & Laboratory Medicine . 2009 (9)
  • 8Giuseppe De Luca,Matteo Santagostino,Gioel Gabrio Secco,Ettore Cassetti,Livio Giuliani,Elena Franchi,Lorenzo Coppo,Sergio Iorio,Luca Venegoni,Elisa Rondano,Gabriele Dell’Era,Claudia Rizzo,Patrizia Pergolini,Francesco Monaco,Giorgio Bellomo,Paolo Marino.Mean platelet volume and the extent of coronary artery disease: Results from a large prospective study[J]. Atherosclerosis . 2009 (1)
  • 9Nasser Lakkis,Hisham Dokainish,Mohamad Abuzahra,Valeri Tsyboulev,Jefferey Jorgensen,Audrie Ponce De Leon,Abdus Saleem.Reticulated platelets in acute coronary syndrome: A marker of platelet activity[J]. Journal of the American College of Cardiology . 2004 (10)
  • 10Suzanne Fateh-Moghadam,Wolfgang Bocksch,Andreas Ruf,Timm Dickfeld,Michael Schartl,Gisela Pogátsa-Murray,Roland Hetzer,Eckart Fleck,Meinrad Gawaz.Changes in Surface Expression of Platelet Membrane Glycoproteins and Progression of Heart Transplant Vasculopathy[J]. Circulation: Journal of the American Heart Association . 2000 (8)

引证文献5

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部